Isuku ryinshi 540737-29-9 Citrate ya Tofacitinib ya JAK Pathway Inhibitor Yerekana Ishusho

Ubuziranenge Bwinshi 540737-29-9 Tofacitinib citrate ya JAK Pathway Inhibitor

Ibisobanuro bigufi:

Isuku:9. 99.0%

Ubuziranenge:Ibigo bisanzwe cyangwa nkuko bisabwa

Ubushobozi:35Kgs / Ukwezi

Ubuzima bwa Shelf:Imyaka itatu

Gusaba:Kuvura rubagimpande ya rubagimpande, arthrite ya psoriatic, ankylose spondylitis na colitis ulcerative

Ibyiza by'itsinda:Inararibonye yo kugurisha ibicuruzwa hanze hamwe namahugurwa yumwuga muruganda

Ohereza imeri kuri twe Kuramo nka PDF

Ibicuruzwa birambuye

Ibibazo

Ibicuruzwa

Ibicuruzwaizina	Tofacitinib Citrate
Synonyme	(3R, 4R) -1- (Cyanoacetyl) -4-methyl-N-methyl-N-1H-pyrrolo -propanetricarboxylate;CP 690500-10;CP 690550-10;(3R, 4R) -4-Methyl-3- (methyl-7H-pyrrolo
URUBANZA No.	540737-29-9
Kugaragara	Kureka ifu yera kugeza yera
Inzira ya molekulari	C₁₆H₂₀N₆OC₆H₈O₇
Uburemere bwa molekile	504.50
Gusaba	Urwego rwa farumasi cyangwa intego yubushakashatsi
Gupakira	Nkurikije icyifuzo cyawe
Ububiko	Bika mubintu byoroshye, birinda urumuri ahantu hakonje

Citrate ya Tofacitinib (CAS #540737-29-9)
INGINGO	STANDARDS	IBISUBIZO
Kugaragara	Kureka ifu yera kugeza yera	Kureka ifu yera
Kumenyekanisha	HPLC;IR;HNMR	Bikubiyemo
Gukemura	Gukemura muri DMSO kuri 100mg / ml, gushonga cyane muri Ethanol, gushonga gake mumazi nibindi.	Bikubiyemo
Gutakaza Kuma	≤0.5%	0,12%
Ibisigisigi byo gutwikwa	≤0.1%	0,05%
Ibyuma biremereye	≤10ppm	Bikubiyemo
Ibintu bifitanye isano	Diastereomer (RS + SR) ≤0.1% Umwanda umwe ≤0.15% Umwanda wose ≤1.0%	0,05% 0.14% 0.18%
Enantiomorphism Isomers	≤0.2%	Bikubiyemo
Ibisigisigi bisigaye	Ethanol ≤5000ppm Methanol ≤3000ppm Toluene ≤890ppm	Bikubiyemo
Ibirimo	36.2% ~ 40%	37.8%
Isuku	≥99.0%	99.38%
Suzuma	60.68% ~ 63.16% ya Tofacitinib INN 98% ~ 102% ya Tofacitinib Citrate INN	62.04% 99,12%
Umwanzuro

Amakuru yisosiyete

Experience Inzego zubuyobozi zifite uburambe mu ruganda hamwe nabatekinisiye babishoboye;
Uality Ubwiza burigihe twibanze hejuru, Sisitemu ya QC;
Years Imyaka 11 ifite uburambe bwo kohereza ibicuruzwa hanze;
Lab Laboratwari yigenga ya R&D;
√ Amahugurwa abiri yashyizweho umukono igihe kirekire GMP;
Resources Ibikoresho byinshi byinganda zidafite akamaro kumushinga wabigenewe;
Team Itsinda rikora neza rifite inzira ihamye.
imgsaf